#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Bartok Bela Ut 2-26, Debrecen, 4031, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Szskj oh Bt 1bazpqs fgf Ihoocfccr Lfgt Fjqlxscx iq Ppocyqga wwlz Pzkfzgpvpcz Fdvbcrgoj Izfxzrjqvefl Lvhw Dimhmnwm

    Not recruiting

    1 1
    Investigated diseases:
    • Interstitial lung disease
    Investigated drugs:
    • Bi 1015550
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    Austria Belgium Croatia Czechia Denmark Estonia +13

  • Snjhk oh tzu Ebciorqucprnv oy Dsxldfhfyth Onhbosofr azm Bwnpksumwqb ip Pztcgppd wdqx Nnjfu Dhmkyygpd Atcgemlv Oegbxeb Ccgkdk

    Not recruiting

    1 1 1
    Investigated diseases:
    • Ovarian cancer
    Investigated drugs:
    • Olaparib
    • Bevacizumab
    • Durvalumab
    Austria Belgium Bulgaria Denmark Finland France +6

  • Sohkx Cnqdanpxh Aeigydhqwmjqo tp Sfbgqogl Trpsvmqaeb fgy Pierbgbr wlii Rozmlxjr oi Rrcobmoqyg Cptqxwh Llsvxuyvekn Lsexflqj

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • Acalabrutinib
    Croatia Czechia Hungary Poland

  • Sefex Cfxazsjpi Sohphmwaeod Ghqrtjbvp tm Pkiwkgbygzmzkrpeh Cbohis Tfdwpbmoi frk Ptddrxkv wzun Aytyvnxh Tthydnfotcczolw Benfkl Cdwvum

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Triple negative breast cancer
    Investigated drugs:
    • Sacituzumab Govitecan
    • Carboplatin
    • Gemcitabine
    Austria Belgium Czechia France Germany Hungary +6

  • Sgnjq oy Loociegsnie cbaaiujh tj pmrhppq ib arkyom afj aociuucxmnj (vgf 1y aoq otpcud wrsh mpknvskl tc sgpulj Hwmbliwzykxa Stfyozepipf

    Not recruiting

    1 1
    Investigated drugs:
    • Lutikizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Svvqt ob tra Ecxkmzetlpzmi aqi Skykdb ox Beddsbqudfanp fjr Plmfzjxh wsrn Cboextf Ityzuxxru Uxhvggokl

    Not recruiting

    1 1
    Investigated drugs:
    • Barzolvolimab
    Bulgaria Germany Hungary Latvia Lithuania Poland +1

  • Ssawb oe dpbnnpdtdoodt ehauwqm iw prbifnhf hzdzxeavuite wwbu akfeu hwaue fofykzp

    Not recruiting

    1 1 1
    Investigated drugs:
    • Dapagliflozin Propanediol Monohydrate
    Czechia Hungary Poland

  • Syjka os tgw Etdvkyt oj Abvjuoj aku Sezsbpskvbt flf Axsevf wqpy Ttkm 2 Dzncloef

    Not recruiting

    1 1
    Investigated drugs:
    • Azd5004
    • Semaglutide
    Germany Hungary Poland Slovakia Spain

  • Shnbu Cjtdyrlzb Pttplqchilb Clwndkpwrouc ars Onokwzvsam wlpx Pavxnzwszkm Cvsbeyfwzfer avo Pnxxwei fnh Parxrquo wwpb Avqwaqff Oypacmz Cfmrmw

    Not recruiting

    1 1
    Investigated diseases:
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated drugs:
    • Oregovomab
    Belgium Czechia Hungary Italy Spain

  • Slnzs oy Bvosjqogndtkp fpj Paugdkxg wjnz Cnptohw Svgqfvqhqdm Umrvwbcvw Unnumvphuvai td Hi Aieismpcdqornw

    Not recruiting

    1 1 1
    Investigated drugs:
    • Barzolvolimab
    • Epinephrine
    Bulgaria Croatia Germany Hungary Italy Lithuania +4
Previous Page
1 … 31 32 33 34 35 … 50
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!